comparemela.com

CHICAGO--(BUSINESS WIRE)--If You Purchased, Paid for, or Provided Reimbursement for the Alzheimer’s Disease Drug Namenda XR or Namenda IR and its AB-rated generic equivalents, between April 14, 2010 through December 31, 2017 (the estimated date that the anticompetitive effects of Generic Defendants’ unlawful conduct...

Related Keywords

New York ,United States ,Alabama ,Nevada ,New Hampshire ,North Carolina ,Vermont ,Florida ,Rhode Island ,Minnesota ,Illinois ,California ,Wisconsin ,New Mexico ,Oregon ,Michigan ,Mississippi ,West Virginia ,Arizona ,Maine ,Tennessee ,South Dakota ,Nebraska ,Idaho ,Massachusetts ,Iowa ,Kansas ,North Dakota ,Utah ,Hawaii ,Amneal Sun Upsher Smith ,Forest Laboratories ,United States District Court ,Sun Pharmaceutical Industries Ltd ,Barr Pharmaceuticals Inc ,Party Payors ,Teva Pharmaceutical Industries Ltd ,Party Payors Brand Defendants ,Cobalt Laboratories Inc ,Southern District Of New York The Court ,Amneal Pharmaceuticals ,Court Order ,Upsher Smith Laboratories ,Reddy Laboratories Inc ,Wockhardt United States ,Merz Gmbh Co ,Merz Pharmaceuticals Gmb ,Reddy Laboratories Ltd ,Teva Pharmaceuticals United States Inc ,Merz Pharma Gmbh Co ,You Purchased ,Provided Reimbursement ,Disease Drug Namenda ,Generic Defendant ,Could Get Money ,Class Action ,Namenda Indirect Purchaser Antitrust Litigation ,Southern District ,Merz Gmbh ,Merz Pharmaceuticals Gmbh ,Merz Pharma Gmbh ,Barr Pharmaceuticals ,Cobalt Laboratories ,Teva Pharmaceutical Industries ,Teva Pharmaceuticals United States ,Wockhardt Limited ,Generic Defendants ,Brand Defendants ,Defendants Class ,All Third Party Payors ,Long Form Notice ,Settlement Agreements ,Generic Defendants Class ,Brand Defendants Class ,Claim Forms ,Claim Form ,Settlement Agreement ,Settling Parties ,Settling Defendants ,Third Party Payors ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.